Memorial Sloan Kettering Cardio Oncology Symposium
2020 MSK Cardio-Oncology Symposium
Modern cancer therapy has significantly improved cancer survival, transforming several once-fatal cancers into chronic disease, but often at the expense of exposure to cardiotoxic drugs. Cardiovascular disease is now a leading cause of morbidity and mortality in cancer survivors as they are living long enough to experience later onset cardiac effects of these treatments. Cardio-oncology is a rapidly evolving field comprised of multidisciplinary care teams focused on improving the outcome of patients with cancer.
The purpose of this conference is to provide a state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer. Clinical experts from Memorial Sloan Kettering Cancer Center and around the country will present an up-to-date overview on cutting edge cancer therapies and best practice strategies in cardiovascular care in cancer patients including preventive strategies, early diagnosis and treatment and long-term surveillance. All presentations will include devoted time for interaction between audience members and presenters.
Bone Marrow Transplant, Cardiology, Critical Care, Emergency Medicine , Endocrinology, Diabetes and Metabolism, Gastroenterology, Gastrointestinal Oncology, Hospice and Palliative Medicine, Internal Medicine , Leukemia, Lymphoma, Medical Oncology, Nurse Practitioner, Nursing, Radiation Oncology.
- Identify common cardiotoxic cancer treatment regimens; its mechanism of action of cardiotoxicity and the resulting cardiovascular disease
- Describe the evaluation and management of CV concerns related to immunotherapy
- Construct cardioprotective strategies prior, during and after cancer therapy
- Evaluate current practice guidelines and incorporation into clinical practice
- Recognize the appropriate use of imaging modalities for cardiotoxicity monitoring; the strengths and weaknesses of each modality including 2D/3D echo, MUGA, CMR and CTA
- Identify the late cardiovascular sequelae of cancer and its treatment